Following FDA clearance earlier this year, Perfuze is putting forward new data comparing its super-bore aspiration catheter to conventional suction methods for removing stroke-causing blood clots, as well as the emerging approach of cyclic aspiration. The three-way benchtop study of the company’s Millipede88 catheter, tested with in vitro models … [Read more...] about Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study
Perfuze
Perfuze wins FDA clearance for standalone aspiration catheter
Perfuze announced today that it received FDA 510(k) clearance for its Millipede88 aspiration catheter. Galway, Ireland–based Perfuze designed the catheter for rapid and complete clot removal in patients suffering from large vessel occlusion (LVO) strokes. The company aims to improve stroke treatment outcomes and reduce procedural … [Read more...] about Perfuze wins FDA clearance for standalone aspiration catheter
Perfuze completes enrollment in stroke catheter study, appoints VP of sales
Perfuze announced today that it completed enrollment in its U.S. FDA investigational exemption (IDE) trial evaluating its stroke treatment. Galway, Ireland-based Perfuze also announced a new personnel appointment, naming Joe Rotger EVP of sales. According to a news release, Perfuze completed enrollment in the MARRS (millipede aspiration for … [Read more...] about Perfuze completes enrollment in stroke catheter study, appoints VP of sales
Perfuze wins FDA nod for access catheter, raises $24M
Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding. The Galway, Ireland–based medtech company picked up about $24 million (€22 million) in a follow-on funding round. Existing investors, including Earlybird, EQT Life Sciences, Seroba and SV Health, participated in the … [Read more...] about Perfuze wins FDA nod for access catheter, raises $24M
FDA clears neurovascular aspiration, access catheters from Perfuze
Perfuze announced today that the FDA cleared its Millipede 070 aspiration catheter and second-generation Millipede 088 access catheter. Galway, Ireland-based Perfuze developed Millipede 070 to address critical unmet needs in ischemic stroke treatment. It aims to remove clots rapidly and safely through a novel, unique catheter. Millipede 070 … [Read more...] about FDA clears neurovascular aspiration, access catheters from Perfuze
FDA clears Perfuze’s Millipede access catheter
Perfuze recently announced that it received FDA 510(k) clearance for its Millipede 088 access catheter. The Galway, Ireland-based company designed Millipede 088 to facilitate the safe insertion and guidance of microcatheters for neurointerventional or diagnostic procedures. The company hopes the device will advance all aspects of stroke … [Read more...] about FDA clears Perfuze’s Millipede access catheter
Perfuze wins CE mark approval for clot aspiration catheter, treats first patients
Perfuze today said it received CE mark approval for its clot aspiration catheter Millipede 088. The Ireland-based company also announced that the first five acute ischemic stroke patients have been treated with the device. “Our initial experience with the device has been very positive, I believe the large bore and distal flow control … [Read more...] about Perfuze wins CE mark approval for clot aspiration catheter, treats first patients
